English | Español
Patient Daily | Mar 30, 2026

Oryon announces $42 million funding for Parkinson’s cell therapy development
Patient Daily | Mar 30, 2026

FDA warns of seizure risk linked to Parkinson’s drugs with levodopa and carbidopa
Patient Daily | Mar 30, 2026

Earendil Labs secures $787 million for AI-driven biologics development
Patient Daily | Mar 30, 2026

Kevin Tang appointed CEO as Aurinia Pharmaceuticals restructures leadership team
Patient Daily | Mar 30, 2026

Gene therapies for hearing loss show promise despite recent setbacks in the field
Patient Daily | Mar 30, 2026

FDA’s new priority voucher program faces questions over transparency and selection process
Patient Daily | Mar 30, 2026

Study examines brain and muscle activity changes in aging and Parkinson’s during balance recovery
Patient Daily | Mar 30, 2026

Webinar to present Cancer Genome Interpreter tool for cancer genomics on April 9

Trending
+ Regulatory
A. D. Alderman | Jun 11, 2026

Pharmacist Crisp on PBM reform bills: 'Middleman that owns the pharmacy, sets the price, pays itself, and audits its own books'
+ Regulatory
A. D. Ahrens | Jun 11, 2026

Economist: 'The 340B program has been hijacked by tax-exempt hospitals'
+ Regulatory
Patient Daily | Jun 16, 2026

PhRMA official: 'A program meant to help vulnerable patients shouldn't be treated like a business strategy'
+ Regulatory
Patient Daily | Jun 12, 2026

Taxpayer advocate: 340B drug discount program offers 'perverse incentives'